ETF Chart of the Day: A Biotech Bet

We spoke about the Biotech sector in the context of a sell-off that began in late March this year instead of April like last year, and the weakness there continues today with the largest product in the space, IBB (iShares Biotech, Expense Ratio 0.48%) flirting with its 50 day moving average again...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.